Editorial Note: Honokiol Inhibits Non-Small Cell Lung Cancer Cell Migration by Targeting PGE2-Mediated Activation of β-Catenin Signaling.
出版信息
PLoS One. 2024 May 13;19(5):e0303600. doi: 10.1371/journal.pone.0303600. eCollection 2024.
Abstract
摘要
相似文献
1
Editorial Note: Honokiol Inhibits Non-Small Cell Lung Cancer Cell Migration by Targeting PGE2-Mediated Activation of β-Catenin Signaling.编辑按语：厚朴酚通过靶向PGE2介导的β-连环蛋白信号激活来抑制非小细胞肺癌细胞迁移。
PLoS One. 2024 May 13;19(5):e0303600. doi: 10.1371/journal.pone.0303600. eCollection 2024.
2
Honokiol inhibits non-small cell lung cancer cell migration by targeting PGE₂-mediated activation of β-catenin signaling.和厚朴酚通过靶向 PGE₂ 介导的β-连环蛋白信号激活抑制非小细胞肺癌细胞迁移。
PLoS One. 2013 Apr 8;8(4):e60749. doi: 10.1371/journal.pone.0060749. Print 2013.
3
Honokiol inhibits EMT-mediated motility and migration of human non-small cell lung cancer cells in vitro by targeting c-FLIP.厚朴酚通过靶向c-FLIP在体外抑制人非小细胞肺癌细胞中EMT介导的运动性和迁移。
Acta Pharmacol Sin. 2016 Dec;37(12):1574-1586. doi: 10.1038/aps.2016.81. Epub 2016 Sep 5.
4
Exploiting Honokiol-induced ER stress CHOP activation inhibits the growth and metastasis of melanoma by suppressing the MITF and β-catenin pathways.利用和厚朴酚诱导的内质网应激 CHOP 激活，通过抑制 MITF 和 β-catenin 通路抑制黑色素瘤的生长和转移。
Cancer Lett. 2019 Feb 1;442:113-125. doi: 10.1016/j.canlet.2018.10.026. Epub 2018 Nov 1.
5
Liposomal honokiol induced lysosomal degradation of Hsp90 client proteins and protective autophagy in both gefitinib-sensitive and gefitinib-resistant NSCLC cells.脂质体霍宁诱导 HSP90 客户蛋白溶酶体降解和保护性自噬在吉非替尼敏感和耐药 NSCLC 细胞中。
Biomaterials. 2017 Oct;141:188-198. doi: 10.1016/j.biomaterials.2017.07.002. Epub 2017 Jul 4.
6
Macrophages induce EMT to promote invasion of lung cancer cells through the IL-6-mediated COX-2/PGE/β-catenin signalling pathway.巨噬细胞通过白细胞介素-6介导的环氧化酶-2/前列腺素E/β-连环蛋白信号通路诱导上皮-间质转化，以促进肺癌细胞的侵袭。
Mol Immunol. 2017 Oct;90:197-210. doi: 10.1016/j.molimm.2017.06.018. Epub 2017 Aug 21.
7
Honokiol induces endoplasmic reticulum stress-mediated apoptosis in human lung cancer cells.和厚朴酚诱导人肺癌细胞内质网应激介导的细胞凋亡。
Life Sci. 2019 Mar 15;221:204-211. doi: 10.1016/j.lfs.2019.01.046. Epub 2019 Jan 29.
8
Honokiol induces apoptosis of lung squamous cell carcinoma by targeting FGF2-FGFR1 autocrine loop.霍诺酚诱导肺鳞癌细胞通过靶向 FGF2-FGFR1 自分泌环诱导细胞凋亡。
Cancer Med. 2018 Dec;7(12):6205-6218. doi: 10.1002/cam4.1846. Epub 2018 Dec 5.
9
Prostaglandin E2 upregulates β1 integrin expression via the E prostanoid 1 receptor/nuclear factor κ-light-chain-enhancer of activated B cells pathway in non-small-cell lung cancer cells.前列腺素E2通过E前列腺素1受体/活化B细胞核因子κ轻链增强子途径上调非小细胞肺癌细胞中β1整合素的表达。
Mol Med Rep. 2014 May;9(5):1729-36. doi: 10.3892/mmr.2014.2000. Epub 2014 Feb 28.
10
Cytological effects of honokiol treatment and its potential mechanism of action in non-small cell lung cancer.霍楠醇处理对非小细胞肺癌的细胞学作用及其潜在作用机制。
Biomed Pharmacother. 2019 Sep;117:109058. doi: 10.1016/j.biopha.2019.109058. Epub 2019 Jun 5.
本文引用的文献
1
Honokiol inhibits non-small cell lung cancer cell migration by targeting PGE₂-mediated activation of β-catenin signaling.和厚朴酚通过靶向 PGE₂ 介导的β-连环蛋白信号激活抑制非小细胞肺癌细胞迁移。
PLoS One. 2013 Apr 8;8(4):e60749. doi: 10.1371/journal.pone.0060749. Print 2013.
Zotero 插件